
Member of the European Parliament · Romania Renew
Vlad Vasile-Voiculescu
MEP for Romania · Renew Europe · Uniunea Salvați România · official EP profile
As of 12 September 2026, Vlad Vasile-Voiculescu (Renew, Romania) has declared 44 lobby meetings this term - rank 391 of 719 MEPs by declared meetings.
That is somewhat below the Parliament average of 85 meetings per MEP, and 68 of 77 within Renew Europe.
76% of this MEP's declared counterpart entries, including diplomatic and government entries, carry a declared EU Transparency Register link - above the like-for-like raw Parliament-wide share of 51%.
Compare with the rest: search and sort all 719 MEPs, or see every MEP from Romania.
Compared with the averages
Transparency this term
Monthly declared meetings (bars) and the share of all counterpart entries carrying a declared Register link, including diplomatic and government entries (line), July 2024 to September 2026. This is the same current-term window as the figures above, beginning 16 July 2024.
Current month, partial through 11 Sep 2026: 0 declared meetings in Sep 2026. Peak: 6 in Jan 2025.
Busiest month: 6 declared in January 2025. Months with no declared meetings have no Register-share value.
Who Vlad Vasile-Voiculescu meets most
| Declared counterpart | Meetings |
|---|---|
| European Society for Paediatric Oncology | 4 |
| European Lung Foundation | 3 |
| European Cancer Organisation | 3 |
| MEDICINES FOR EUROPE | 2 |
| Apple Inc. | 2 |
Counterparts are merged by resolved Transparency Register identity where possible. An entry counts as register-linked above only when the MEP declaration itself carries a Register link.
Where the meetings cluster
Most-met sectors
Health & pharma (37), Technology & digital (3), Public affairs & consultancy (2)
Meetings by committee topic
Public Health (43), Development (1), Environment, Climate and Food Safety (1)
Most recent declared meetings
| Date | Counterpart | Capacity | Subject |
|---|---|---|---|
| 25 Mar 2026 | European Organisation for Research and Treatment of Cancer ↗ | Member | Intro meeting |
| 24 Mar 2026 | Novartis International AG ↗ | Member | Intro meeting |
| 16 Mar 2026 | European Federation of Pharmaceutical Industries and Associations ↗ | Rapporteur | EBCP report |
| 12 Mar 2026 | Biohit Oyj | Rapporteur | Cancer prevention and screening |
| 3 Mar 2026 | European Society for Paediatric Oncology ↗ | Rapporteur | Childhood cancer |
| 12 Feb 2026 | European Cancer Organisation ↗ | Rapporteur | Cancer prevention |
| 7 Oct 2025 | Apple Inc. ↗ | Member | Intro Meeting |
| 10 Sep 2025 | Amgen Inc ↗ | Shadow rapporteur | Meeting CMA |
| 14 Jul 2025 | AstraZeneca PLC ↗; Merck Sharp & Dohme Europe Belgium SRL ↗ | Shadow rapporteur | Meeting CMA |
| 10 Jul 2025 | Asociatia Distribuitorilor Europeni de Medicamente | Member | Intro Meeting |
Show 20 more meetings
| Date | Counterpart | Capacity | Subject |
|---|---|---|---|
| 8 Jul 2025 | CSL Behring ↗ | Shadow rapporteur | Meeting CMA |
| 3 Jul 2025 | MedTech Europe ↗ | Member | Intro Meeting |
| 26 Jun 2025 | Shionogi Europe B.V. | Member | Introductory Meeting |
| 24 Jun 2025 | Novartis International AG | Member | Introductory Meeting |
| 17 Jun 2025 | Vaccines Europe | Member | Introductory Meeting |
| 21 May 2025 | European Confederation of Pharmaceutical Entrepreneurs; Rud Pedersen Public Affairs Brussels; Fondazione Telethon ETS | Member | Introductory Meeting |
| 20 May 2025 | Pharmaceutical Group of the European Union | Member | Introductory Meeting |
| 6 May 2025 | MEDICINES FOR EUROPE | Member | Urban Wastewater Treatment Directive |
| 30 Apr 2025 | EUROPA DONNA-The European Breast Cancer Coalition ↗ | Member | Introductory meeting |
| 5 Feb 2025 | CCI Europe ↗ | Member | Follow-Up CCI |
| 4 Feb 2025 | European Lung Foundation ↗ | Member | Follow up Respiratory Strategy |
| 4 Feb 2025 | European Public Health Alliance ↗ | Member | Introductory Meeting |
| 29 Jan 2025 | Asociația Română a Producătorilor de medicamente fără prescripție, suplimente alimentare și dispozitive medicale; Association of the European Self-Care Industry ↗ | Member | Introductory Meeting |
| 28 Jan 2025 | MEDICINES FOR EUROPE ↗ | Member | Introductory Meeting |
| 22 Jan 2025 | European Lung Foundation ↗ | Member | Follow-up Respiratory Initiative |
| 17 Jan 2025 | Pancreatic Cancer Europe ↗ | Member | Introductory Meeting |
| 15 Jan 2025 | European Society for Paediatric Oncology ↗; European Cancer Organisation ↗; EUROPEAN ORGANISATION FOR RARE DISEASES ↗ | Member | Intergroup on cancer and rare diseases |
| 14 Jan 2025 | European Liberal Forum ↗ | Member | Introductory Meeting |
| 18 Dec 2024 | AbbVie ↗ | Member | Introductory Meeting |
| 17 Dec 2024 | European Lung Foundation ↗ | Member | Introductory Meeting |
The full record is in the official EP declarations.
Roll-call voting record
Recorded votes only. Parliament held 5,568 roll-call votes while Vlad Vasile-Voiculescu held the seat, 537 of them the final vote on a text. A member with no vote recorded may have been on parliamentary business, ill, on leave, or present without voting - the published record does not distinguish these and gives no reason. Votes taken by show of hands or by secret ballot are not recorded by name and are absent here.
How they voted on final texts
Share of the 537 final votes held while seated.
With and against the group
On the 428 final texts where more than half of Renew members casting a vote went one way, and Vlad Vasile-Voiculescu also voted. Groups are not bound to vote together: a Member's mandate is personal and exercised freely, so neither figure is a measure of performance.
Final texts where Vlad Vasile-Voiculescu differed from the Renew majority
| Date | Text | Their vote | Renew majority |
|---|---|---|---|
| 8 July 2026 | B10-0335/2026 – Motion for a resolution (as a whole) | For | Against |
| 8 July 2026 | A10-0163/2026 – Tonino Picula – Motion for a resolution (as a whole) | Abstained | For |
| 11 February 2026 | B10-0108/2026 – Motion for a resolution | For | Against |
| 11 February 2026 | B10-0109/2026 – Motion for a resolution | For | Against |
| 11 February 2026 | B10-0106/2026 – Motion for a resolution | For | Against |
| 16 December 2025 | B10-0559/2025 – Motion for a resolution | For | Against |
| 16 December 2025 | B10-0562/2025 – Motion for a resolution | For | Against |
| 19 June 2025 | RC-B10-0291/2025 – Motion for a resolution (as a whole) | Against | For |
| 8 May 2025 | C10-0044/2025 - Proposition de la Commission | Against | For |
| 8 May 2025 | B10-0244/2025 - Proposition de résolution | For | Against |
6 further instances are not listed. All roll-call votes.
Unlinked but matchable
10 counterpart entrys in Vlad Vasile-Voiculescu's declarations appear to match an EU Transparency Register entry without being linked in the declaration:
- “Asociatia Distribuitorilor Europeni de Medicamente” - likely Asociatia Distribuitorilor Europeni de Medicamente (1 counterpart entry)
- “Biohit Oyj” - likely Biohit Oyj (1 counterpart entry)
- “European Confederation of Pharmaceutical Entrepreneurs” - likely European Confederation of Pharmaceutical Entrepreneurs (1 counterpart entry)
Matching is automated and can be wrong - see how matching works. Linking the register entry is the fix, and it is the MEP office's to make.